课题基金 / 基金详情

NCI CBIIT PROGRAM MANAGEMENT SUPPORT

NCI CBIIT PROGRAM MANAGEMENT SUPPORT
NCI CBIIT 项目管理支持
批准号:
8332524
负责人:
MATT BURDETSKY
金额:
$35.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

MATT BURDETSKY的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The cancer Biomedical Informatics Grid(R) (caBIG(R)) developed by the National Cancer Institute (NCI), helps overcome several critical obstacles to enabling personalized medicine in the 21st century. caBIG(R) helps leverage large quantities of genomic and clinical data through multidisciplinary, collaborative research to bring new diagnostics and therapeutics to bear on cancer and other diseases, more quickly and potentially at reduced cost, ultimately leading to improved patient outcomes. By implementing a semantically and syntactically interoperable information technology (IT) infrastructure to connect the 60+ NCI-designated Comprehensive Cancer Centers to one another and to the broader biomedical community, caBIG(R) is already having a transformative impact on cancer research in the United States. The caBIG(R) program is not just a technology stack of software tools but more importantly is a rich community of diverse stakeholders including researchers, clinicians, administrators, patient advocates, and other stakeholders from Government, academia, and industry. Though the NCI designed this program for the purpose of accelerating discovery toward better detection, treatment, and prevention of cancer, it was also designed to be extended to support the same endeavor for other medical conditions. To that end, the NCI has launched a sister initiative called BIG Health, with a purpose to facilitate utilization of caBIG(R) technology beyond cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CONFERENCE & MEETING SUPPORT SERV. F/THE DNBBS, NIMH
  • 批准号:
    7542405
  • 项目类别:
  • 资助金额:
    $4.3万
  • 财政年份:
    2005
  • 负责人:
    MATT BURDETSKY
  • 依托单位:
    --
NHP Reagent Resource for immune-mediated diseases, tranplantation, and infectious
Task 03 (F02): NDA Enabling Nonclinical Studies for Evaluation of ST-246
  • 批准号:
    8332207
  • 项目类别:
  • 资助金额:
    $0.22万
  • 财政年份:
    2004
  • 负责人:
    MATT BURDETSKY
  • 依托单位:
Vaccine and Treatment Evaluation Units (VTEUs)
  • 批准号:
    8351909
  • 项目类别:
  • 资助金额:
    $15.45万
  • 财政年份:
    2002
  • 负责人:
    MATT BURDETSKY
  • 依托单位:
海外基金